Precision Psychiatry Market Aimed at USD 10.2 Billion by 2032, Rising at 7.47% CAGR

Precision Psychiatry Market Growth Research Report and Trends Analysis By Application (Neuroimaging, Genetic Testing, Biomarkers Analysis, Digital Therapeutics), By Therapeutic Area (Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia), By Technology (Machine Learning, Artificial Intelligence, Cloud Computing), By End Use (Hospitals, Research Institutions, Clinics) and  By Regions  - Forecast to 2032

According to MRFR Precision Psychiatry Market market's size, share, growth, opportunity, competitive environment, manufacturers, players, and vendors, as well as its segments and sub-segments, is provided by this intelligence research outlook. In-depth analysis of the price trend to bring forth the monthly, quarterly, half-yearly, and yearly information on in its latest pricing dashboard.

The Precision Psychiatry Market is emerging as a transformative force in mental healthcare, driven by advancements in genomics, AI, and personalized treatment protocols. Valued at USD 5.73 billion in 2024, up from USD 5.34 billion in 2023, the market is projected to reach USD 10.2 billion by 2032, expanding at a CAGR of 7.47% during the forecast period of 2025 to 2032. For B2B stakeholders—including pharmaceutical companies, genetic testing providers, AI developers, and digital health platforms—this market offers high-growth opportunities in a rapidly evolving segment of healthcare.

Request To Free Sample of This Strategic Report: https://www.wiseguyreports.com/sample-request?id=652959 

Market Overview and Key Dynamics

From 2019 to 2024, the Precision Psychiatry Market has grown steadily as traditional mental health approaches increasingly give way to data-driven and personalized methods. Precision psychiatry integrates genetics, neuroimaging, biomarkers, and digital technologies to tailor treatments for disorders such as depression, schizophrenia, bipolar disorder, and anxiety.

Key market dynamics include:

• Increasing prevalence of mental disorders, especially depression, anxiety, and substance use disorders
• Advancements in genomic technologies enabling better disease classification and treatment response prediction
• Growing demand for personalized treatment for improved efficacy and reduced side effects
• Rising awareness and acceptance of mental health conditions, supported by global campaigns
• Integration of AI in healthcare, enabling predictive analytics and customized therapy plans

These dynamics are redefining how psychiatric care is delivered and opening new B2B collaboration channels across the mental health value chain.

Market Segmentation

The Precision Psychiatry Market is segmented by application, therapeutic area, technology, end use, and region. This allows businesses to identify specific growth pockets and develop targeted strategies.

1. By ApplicationIncludes diagnostics, treatment selection, and monitoring. Diagnostics and treatment selection are leading segments due to the need for accurate diagnosis and treatment optimization.
2. By Therapeutic AreaFocuses on major depressive disorder, schizophrenia, bipolar disorder, anxiety, PTSD, and autism spectrum disorders. Major depressive disorder and schizophrenia dominate due to high global prevalence and clinical complexity.
3. By TechnologyIncludes genomic testing, neuroimaging, AI and machine learning tools, and digital biomarkers. Genomic testing and AI-powered decision support systems are key growth drivers due to their application in personalized treatment.
4. By End UseCovers hospitals, psychiatric clinics, research institutions, and telepsychiatry platforms. Psychiatric clinics and telehealth providers are growing rapidly due to the need for scalable mental health access.
5. By Region

• North America leads the market with robust R&D infrastructure, early adoption of AI and genetics, and supportive reimbursement frameworks
• Europe follows with increased mental health funding and expanding genomic research capabilities
• Asia-Pacific (APAC) is the fastest-growing region due to rising mental health awareness, expanding healthcare access, and population-scale screening initiatives
• South America and MEA are emerging regions offering long-term potential through telepsychiatry expansion and public health campaigns

You Can Purchase Complete Report: https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=652959 

Competitive Landscape

The Precision Psychiatry Market is becoming increasingly competitive with major pharmaceutical, biotech, and digital health players investing in innovation and strategic partnerships.

Key companies profiled include:

• Roche
• H. Lundbeck A/S
• Pfizer
• GSK
• Bristol Myers Squibb
• Novartis
• Otsuka Pharmaceutical
• AbbVie
• Johnson & Johnson
• Eli Lilly and Company
• Merck & Co.
• Takeda Pharmaceutical Company
• Acadia Pharmaceuticals
• Sanofi
• AstraZeneca

These companies are advancing clinical pipelines, investing in digital mental health technologies, and collaborating with genomics firms and AI platforms to strengthen their foothold in precision psychiatry.

Industry Trends

Several key trends are shaping the future of the Precision Psychiatry Market:

• Personalized treatment plans based on patient-specific biomarkers, genetics, and environmental data
• Advancements in genetic testing enabling pharmacogenomics and individualized drug selection
• AI technologies supporting diagnostics, early intervention, and treatment monitoring
• Expansion of telepsychiatry services offering remote access to mental healthcare
• Growing awareness and education initiatives improving public understanding and reducing stigma

These trends are creating a technology-enabled ecosystem where B2B collaboration is critical to delivering advanced mental health solutions.

Market Opportunities

For B2B enterprises, the Precision Psychiatry Market presents several key opportunities:

• Personalized treatment plans supported by diagnostic platforms, genetic labs, and software vendors
• Advancements in genetic testing requiring scalable laboratory services and analytics platforms
• Integration of AI technologies with EHR systems, clinical decision support, and virtual care models
• Expansion of telepsychiatry services through partnerships with clinics, health systems, and digital platforms
• Educational programs and mental health campaigns creating demand for training, tools, and diagnostics

These opportunities enable companies to build high-value offerings that improve outcomes and streamline psychiatric care delivery.

Browse In-depth Market Research Report (Pages, Charts, Tables, Figures): https://www.wiseguyreports.com/reports/precision-psychiatry-market 

Strategic Outlook

Between 2025 and 2032, the Precision Psychiatry Market will transition from early-stage innovation to mainstream adoption. B2B stakeholders that focus on interoperability, evidence-based outcomes, and regulatory readiness will gain competitive advantage. Partnerships between pharmaceutical companies, AI startups, genetic testing labs, and healthcare providers will play a pivotal role in scaling precision psychiatry.

Strategic Insights and Benefits of This Precision Psychiatry Market Report

Understand Next-Gen AI Dynamics: Gain comprehensive insights into agentic AI adoption patterns, multimodal integration strategies, and quantum-enhanced computing applications across different Precision Psychiatry Market segments.

Identify Emerging Growth Opportunities: Discover cutting-edge niches within Precision Psychiatry Market AI, from autonomous decision-making systems to quantum-enhanced applications that represent significant untapped market potential.

Navigate AI Governance Evolution: Understand the evolving regulatory and governance landscape for advanced AI systems, including agentic AI compliance, safety-critical system requirements, and international AI standards.

Assess Advanced Technology Readiness: Evaluate the maturity levels of breakthrough AI technologies including quantum AI, small language models, and autonomous reasoning systems in Precision Psychiatry Market applications.

Leverage Cost-Efficiency Trends: Capitalize on falling inference costs and improved hardware efficiency to maximize ROI from AI investments while maintaining competitive advantages.

Avail This Precision Psychiatry Market Language Pages Here:

精密精神医学市場規模 | Marktanteil der Präzisionspsychiatrie | Analyse du marché de la psychiatrie de précision | 정밀 정신의학 시장 분석 | 精准精神病学市场概览| Tendencias del mercado de la psiquiatría de precisión

Other Related Reports from WiseGuy Research References

Pet Dog Allergy Treatment Market - https://www.wiseguyreports.com/reports/pet-dog-allergy-treatment-market

ペット犬アレルギー治療市場規模 | Marktanteil der Behandlung von Hundeallergien | Analyse du marché des traitements contre les allergies aux chiens de compagnie | 반려견 알레르기 치료제 시장 분석 | 预制牙冠市场概览 | Tendencias del mercado de tratamientos para alergias caninas

Protein Peptide Therapeutics Market - https://www.wiseguyreports.com/reports/protein-peptide-therapeutics-market

タンパク質ペプチド治療薬市場規模 | Marktanteil von Protein-Peptid-Therapeutika | Analyse du marché des thérapies à base de protéines et de peptides | 단백질 펩타이드 치료제 시장 분석 | 宠物狗过敏治疗市场概况 | Tendencias del mercado de terapias con péptidos proteicos

Plasma Derived Factor Viii Market - https://www.wiseguyreports.com/reports/plasma-derived-factor-viii-market

血漿由来第VIII因子市場規模 | Marktanteil von aus Plasma gewonnenem Faktor VIII | Analyse du marché du facteur VIII dérivé du plasma | 혈장 유래 인자 Viii 시장 분석 | 蛋白质肽治疗市场概况 | Tendencias del mercado del factor VIII derivado del plasma

Qa Dosimeter Market - https://www.wiseguyreports.com/reports/qa-dosimeter-market

Qa線量計市場規模 | Marktanteil von Qa-Dosimetern | Analyse du marché des dosimètres Qa | QA 선량계 시장 분석 | 血浆衍生因子 Viii 市场概览 | Tendencias del mercado de dosímetros de calidad

Pet Parasite Prevention Control Drugs Market - https://www.wiseguyreports.com/reports/pet-parasite-prevention-control-drugs-market

ペット寄生虫予防管理薬市場規模 | Marktanteil von Medikamenten zur Parasitenprävention bei Haustieren | Analyse du marché des médicaments antiparasitaires pour animaux de compagnie | 반려동물 기생충 예방 및 관리 약물 시장 분석 | Qa 剂量计市场概览 | Tendencias del mercado de medicamentos para el control de parásitos en mascotas

Pharmaceutical Grade Lactose Market - https://www.wiseguyreports.com/reports/pharmaceutical-grade-lactose-market

医薬品グレード乳糖市場規模 | Marktanteil von Laktose in pharmazeutischer Qualität | Analyse du marché du lactose de qualité pharmaceutique | 제약 등급 락토오스 시장 분석 | 宠物寄生虫预防控制药物市场概况 | Tendencias del mercado de la lactosa de grado farmacéutico

Otc Drug And Dietary Supplement Market - https://www.wiseguyreports.com/reports/otc-drug-and-dietary-supplement-market

市販薬および栄養補助食品の市場規模 | Marktanteile rezeptfreier Arzneimittel und Nahrungsergänzungsmittel | Analyse du marché des médicaments en vente libre et des compléments alimentaires | OTC 의약품 및 건강 보조 식품 시장 분석 | 医药级乳糖市场概况 | Tendencias del mercado de medicamentos de venta libre y suplementos dietéticos

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets.